Labisia pumila Upregulates Peroxisome Proliferator-Activated Receptor Gamma Expression in Rat Adipose Tissues and 3T3-L1 Adipocytes (original) (raw)

Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance

Cordelia Barrick

Proceedings of the National Academy of Sciences of the United States of America, 2005

View PDFchevron_right

PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo

Hong-Ping Guan

American journal of physiology. Endocrinology and metabolism, 2007

View PDFchevron_right

Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake

Silvia Wein, Siegfried Wolffram

Phytotherapy Research, 2009

View PDFchevron_right

PPAR regulates adipose triglyceride lipase in adipocytes in vitro and in vivo

Hong-Ping Guan

AJP: Endocrinology and Metabolism, 2007

View PDFchevron_right

Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats

Jay Strum

BMC pharmacology, 2004

View PDFchevron_right

Adipose depot-specific effects of PPARgamma agonists: a consequence of differential expression of PPARgamma in adipose tissue depots?

Carl Montague

Diabetes, Obesity and Metabolism, 2002

View PDFchevron_right

Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: possible involvement of PPAR activation

Alexandra W Einerhand

Lipids in health and disease, 2005

View PDFchevron_right

Hormone-sensitive lipase modulates adipose metabolism through PPARγ

Shailja Patel, Li-fen Liu

Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2011

View PDFchevron_right

PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1

Hong-Ping Guan

The Journal of clinical investigation, 2005

View PDFchevron_right

PPAR-γ response element activity in intact primary human adipocytes: effects of fatty acids

Mats Söderström

Nutrition, 2006

View PDFchevron_right

PPARδ agonists have opposing effects on insulin resistance in high fat-fed rats and mice due to different metabolic responses in muscle

Ji-ming Ye

British Journal of Pharmacology, 2011

View PDFchevron_right

PPAR gamma 2 Prevents Lipotoxicity by Controlling Adipose Tissue Expandability and Peripheral Lipid Metabolism

Antonio Vidal-Puig

PLOS Genetics, 2007

View PDFchevron_right

Cross-Talk between PPAR𝛾 and Insulin Signaling and Modulation of Insulin Sensitivity

Luigi Laviola, Sebastio Perrini

PPAR Research, 2009

View PDFchevron_right

PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes

Geneviève Cordonnier

Atherosclerosis, 1998

View PDFchevron_right

The role of PPARγ in high-fat diet-induced obesity and insulin resistance

Mitsuhiko NODA

Journal of Diabetes and its Complications, 2002

View PDFchevron_right

WY14,643, a Peroxisome Proliferator-activated Receptor α (PPARα) Agonist, Improves Hepatic and Muscle Steatosis and Reverses Insulin Resistance in Lipoatrophic A-ZIP/F-1 Mice

Oksana Gavrilova

Journal of Biological Chemistry, 2002

View PDFchevron_right

Correlation between Adiponectin Receptor (AdipoR) with Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), Peroxisome Proliferator-Activated Receptor Gamma (PPAR-ϒ), and p38-mitogen-activated protein kinases (MAPK) in Type 2 Diabetic Rats Treated with Puguntano (Turanga feel-terrae Lou...

santi syafril

SCITEPRESS - Science and Technology Publications, 2019

View PDFchevron_right

PPARgamma activation attenuates T-lymphocyte-dependent inflammation of adipose tissue and development of insulin resistance in obese mice

Thomas Unger

Cardiovascular Diabetology, 2010

View PDFchevron_right

Adipogenesis and lipotoxicity: role of peroxisome proliferator-activated receptor γ (PPARγ) and PPARγcoactivator-1 (PGC1)

Sarah Gray

Public Health Nutrition, 2007

View PDFchevron_right

A futile metabolic cycle activated in adipocytes by antidiabetic agents

Claire Steppan

Nature Medicine, 2002

View PDFchevron_right

Roles of PPAR delta in lipid absorption and metabolism: a new target for the treatment of type 2 diabetes

Joaquin Lopez Soriano

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005

View PDFchevron_right

The Link Between Nutritional Status and Insulin Sensitivity Is Dependent on the Adipocyte-Specific Peroxisome Proliferator-Activated Receptor- 2 Isoform

Jaswinder K Sethi, William Colledge

Diabetes, 2005

View PDFchevron_right

Improved insulin sensitivity after treatment with PPARγ and PPARα ligands is mediated by genetically modulated transcripts

Neeraj Sharma

Pharmacogenetics and Genomics, 2012

View PDFchevron_right

Overexpression of PPARγ Specifically in Pancreatic β-Cells Exacerbates Obesity-Induced Glucose Intolerance, Reduces β-Cell Mass, and Alters Islet Lipid Metabolism in Male Mice

Heli Nygren

Endocrinology, 2014

View PDFchevron_right

Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator–activated receptor α agonist

Mary Demarest

Metabolism-clinical and Experimental, 2008

View PDFchevron_right

Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity

Lise Madsen

Journal of Biological Chemistry, 2000

View PDFchevron_right

Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action

Theodore Ciaraldi

Diabetologia, 2000

View PDFchevron_right

PPAR activation in adipocytes is sufficient for systemic insulin sensitization

Maziyar Saberi

Proceedings of the National Academy of Sciences, 2009

View PDFchevron_right

Opposite regulation of PPAR-α and -γ gene expression by both their ligands and retinoic acid in brown adipocytes

Marta Giralt

Mol Cell Endocrinol, 1999

View PDFchevron_right

A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

Eric Niesor

Molecular Endocrinology, 2006

View PDFchevron_right